During the first BASIC meeting, Council members received updates on several ongoing pilot activities including the Observational Medical Outcomes Partnership (OMOP), Mini-Sentinel, the Exploring and Understanding Adverse Drug Reactions (EU-ADR) Project, and the Vaccine Safety Datalink.
Recognizing similarities among these pilot activities, the Council considered potential opportunities for sharing findings and minimizing overlap. Following a presentation by McKinsey & Company on lessons learned from public-private partnerships and complex alliances in other industries, the Council discussed governance of the Sentinel System. Specifically, Council members explored the merits of potential organizational models focusing on governance for multiple users and multiple uses, economic sustainability, and ensuring participation of appropriate stakeholders.
Johnson & Johnson and the Observational Medical Outcomes Partnership
Sentinel Initiative Scientific Lead, Office of Medical Policy, Center for Drug Evaluation and Research
Center for Medication Safety PSCI, Department of Veterans Affairs National Center for Patient Safety and Pharmacy Benefits Management Services
Pharmacovigilance Center, United States Army, Office of the Surgeon General
Professor and Chair, Department of Population Medicine - Harvard Pilgrim Health Care Institute
Department of Medical Informatics and Epidemiology, Erasmus University Medical Center
Office of Prevention through Healthcare, Office of the Director for Policy, Centers for Disease Control and Prevention
Center for Outcomes and Evidence, Agency for Healthcare Research and Quality
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.